Syncona Portfolio Ltd

Fundamental diversified ★Signal healthcare specialist (100%) CIK 1725042
Long book
$25.7M
Q1 2026
Positions
2
Top-10 weight
100%
concentration
Last quarter
+13.7%
SPY +14.8%
Turnover
0%
of book per quarter

Strategy in plain words

auto-generated from filings

Syncona Portfolio Ltd is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $25.7M US long book across 2 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: AUTOLUS THERAPEUTICS PLC, CENTURY THERAPEUTICS INC.

Over the last 9 quarters its long book ran on average 13.6pp per quarter behind the S&P 500, beating the index in 2 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-45.5%
Q2 2024
+3.1%
Q3 2024
-35.4%
Q4 2024
-34.6%
Q1 2025
+46.4%
Q2 2025
-28.2%
Q3 2025
+23.8%
Q4 2025
-25.1%
Q1 2026
+13.7%

Sector allocation

Healthcare
100%

Long book by quarter

$150.1M
Q1 2024
$85.9M
Q2 2024
$80.7M
Q3 2024
$53.0M
Q4 2024
$26.4M
Q1 2025
$38.6M
Q2 2025
$27.7M
Q3 2025
$34.3M
Q4 2025
$25.7M
Q1 2026

What does Syncona Portfolio own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
IPSC CENTURY THERAPEUTICS INCHealthcare1.2M$2.7M10.7%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 14, 20262$25.7M canonicalSEC ↗
Q4 202513F-HRFeb 5, 20262$34.3M canonicalSEC ↗
Q3 202513F-HRNov 6, 20252$27.7M canonicalSEC ↗
Q2 202513F-HRAug 7, 20252$38.6M canonicalSEC ↗
Q1 202513F-HRMay 7, 20253$26.4M canonicalSEC ↗
Q4 202413F-HRFeb 6, 20253$53.0M canonicalSEC ↗
Q3 202413F-HRNov 14, 20243$80.7M canonicalSEC ↗
Q2 202413F-HRAug 13, 20243$85.9M canonicalSEC ↗
Q1 202413F-HRMay 7, 20242$150.1M canonicalSEC ↗